Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
D-Sight S.L. logo — Spin-off company from VHIR developing new innovative treatme...

D-Sight S.L.

Spin-off company from VHIR developing new innovative treatments for neurodegenerative diseases of the retina.

Founded 2023 Spain Spain 2 employees Seed Total: $1.00M Biotechnology, Health Care

General Information

Company Name D-Sight S.L.
Founded Year 2023
Location Spain Spain +1
Employees 2
Industries Biotechnology, Health Care
Funding Stage Seed
Social

Get notified when D-Sight S.L. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About D-Sight S.L.

D-Sight S.L., a promising biotech venture, is a spin-off company from the Vall d’Hebron Institute of Research (VHIR) established in 2023. Focused on the biotechnology and healthcare sectors, D-Sight seeks to innovate treatments for neurodegenerative retina diseases.

At the forefront of their development is a potentially transformative first-in-class eye drop aimed at preventing and treating diabetic retinopathy during its initial stages. This innovation highlights D-Sight’s commitment to reshaping how retinal diseases are treated.

Headquartered in Spain, D-Sight attracted significant attention from investors, securing a €1.00M seed round investment from Clave Capital in May 2023. Led by an experienced team with a strong connection to VHIR, the company's strategic focus on unmet needs in retina healthcare positions it as a compelling opportunity for investment in the biotech field.

Taxonomy: neurodegenerative diseases, retina health, diabetic retinopathy, preventable blindness, innovative treatments, eye drop formulation, early-stage intervention, pharmaceutical development, retinal diseases, biopharmaceuticals, vision care, spin-off company, medical research

Services & Products

Development of neuroprotective eye drops
Research and clinical translation for retinal diseases
Non-invasive early-stage intervention solutions

Target Customers

Individuals with diabetic retinopathy Individuals with glaucoma Patients at risk of vision loss

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round - D •••••• 1
Investor
03 May 2023

D-Sight S.L. Alternatives & Competitors

View All Alternatives
D-Sight S.L. vs
RudaCure
RudaCure Korea South

For your quality and painless life

Series A
13 employees
Biotechnology, Pharmaceutical
D-Sight S.L. vs
Artax Biopharma Inc
Artax Biopharma Inc

Developing oral first-in-class Nck blockers for the treatment of T cell mediated autoimmune diseases

Series Unknown
14 employees
Biopharma, Biotechnology
D-Sight S.L. vs
Abeona Therapeutics
Abeona Therapeutics United States

Working together to find a cure

IPO
238 employees
Biotechnology, Health Care
View all alternatives

FAQ About D-Sight S.L.

Spin-off company from VHIR developing new innovative treatments for neurodegenerative diseases of the retina.
D-Sight S.L. was founded in 2023.
D-Sight S.L. is headquartered in Spain.
D-Sight S.L. operates in the following industries: Biotechnology, Health Care.
D-Sight S.L. has approximately 2 employees.
D-Sight S.L. has completed 1 funding round, raising a total of $1.00M. The latest funding stage is Seed.
D-Sight S.L. offers: Development of neuroprotective eye drops, Research and clinical translation for retinal diseases, Non-invasive early-stage intervention solutions.
Top alternatives and competitors to D-Sight S.L. include RudaCure, Artax Biopharma Inc, Abeona Therapeutics, Evelo Biosciences, UNITY Biotechnology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
D-Sight S.L. and RudaCure are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors D-Sight S.L. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy